The approval allows Microsure to begin clinical use of its MUSA-3 microsurgical robotics system in Europe, while the appointment of Alex Joseph as CEO signals a shift from product development toward evidence generation, hospital adoption, and commercial execution. ...
The agreement supports Dentsply Sirona’s focus on disciplined distribution expansion, customer centricity, and localised commercial execution through established partners...
As COO, Testa’s responsibilities will span global operations, and he will oversee Confluent’s operations, supply chain, and global product development...
Funding to accelerate development of real-time imaging solutions aimed at improving surgical precision and patient outcomes...
Voice-driven technology automates clinical note-taking, reducing administrative burden and improving patient engagement in eye care practices...
Deal Positions Stryker To Expand Into High Growth Intravascular Lithotripsy Segment And Address Complex Calcified Arterial Disease...
Eitan Medical’s Avoset platform integrates programmable delivery modes and digital connectivity to improve safety and personalization in regional anesthesia...
The Spur Stent System was granted FDA De Novo clearance in a high-risk, long-lesion population...
The sensor is designed for comfortable 14-15 day wear, reducing the frequency of changes compared to some alternatives...
The Company has acquired the rights to develop, manufacture, and commercialise CARDAMYST (etripamil) nasal spray in Greater China...
